InvestorsObserver is giving Kintara Therapeutics Inc (KTRA) an Analyst Rating Rank of 5, meaning KTRA is ranked higher by analysts than 5% of stocks. The average price target for KTRA is $250 and analyst’s rate the stock as a Hold.
Wall Street analysts are rating KTRA a Hold today. Find out what this means to you and get the rest of the rankings on KTRA!
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With Kintara Therapeutics Inc Stock Today?
Kintara Therapeutics Inc (KTRA) stock is up 17.37% while the S&P 500 is lower by -1.46% as of 2:21 PM on Monday, Nov 28. KTRA has risen $0.64 from the previous closing price of $3.69 on volume of 8,946,246 shares. Over the past year the S&P 500 is lower by -14.77% while KTRA is lower by -87.97%. KTRA lost -$19.24 per share the over the last 12 months.
Click Here to get the full Stock Report for Kintara Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
